☰

Sidong Huang, Ph.D. - Publications

Affiliations: 
2003 University of California, San Francisco, San Francisco, CA 
Area:
signal transduction, transcriptional regulation
Tree Info Similar researchers PubMed Report error

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Zhu X, Fu Z, Dutchak K, Arabzadeh A, Milette S, Steinberger J, Morin G, Monast A, Pilon V, Kong T, Adams BN, Prando Munhoz E, Hosein HJ, Fang T, Su J, ... ... Huang S, et al. Co-targeting CDK4/6 and BRD4 promotes senescence and ferroptosis sensitivity in cancer. Cancer Research. PMID 38277141 DOI: 10.1158/0008-5472.CAN-23-1749  0.321
2020 Xue Y, Zhu X, Meehan B, Venneti S, Martinez D, Morin G, Itoua Maïga R, Chen H, Papadakis AI, Johnson RM, O'Sullivan MJ, Erdreich-Epstein A, Gotlieb WH, Park M, Judkins AR, ... ... Huang S, et al. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology. PMID 32558936 DOI: 10.1002/Path.5493  0.332
2020 Tischkowitz M, Huang S, Banerjee S, Hague J, Hendricks WPD, Huntsman DG, Lang JD, Orlando KA, Oza AM, Pautier P, Ray-Coquard I, Trent JM, Wichter M, Witkowski L, McCluggage WG, et al. Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32156746 DOI: 10.1158/1078-0432.Ccr-19-3797  0.331
2019 Kong T, Xue Y, Cencic R, Zhu X, Monast A, Fu Z, Pilon V, Sangwan V, Guiot MC, Foulkes WD, Porco JA, Park M, Pelletier J, Huang S. eIF4A inhibitors suppress cell cycle feedback response and acquired resistance to CDK4/6 inhibition in cancer. Molecular Cancer Therapeutics. PMID 31395685 DOI: 10.1158/1535-7163.Mct-19-0162  0.395
2019 Shorstova T, Marques M, Su J, Johnston J, Kleinman CL, Hamel N, Huang S, Alaoui-Jamali MA, Foulkes WD, Witcher M. SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research. PMID 30877105 DOI: 10.1158/0008-5472.Can-18-1545  0.418
2019 Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, ... ... Huang S, et al. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558. PMID 30718512 DOI: 10.1038/S41467-018-06958-9  0.423
2019 Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, ... ... Huang S, et al. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nature Communications. 10: 557. PMID 30718506 DOI: 10.1038/S41467-019-08380-1  0.407
2019 Rayes RF, Mouhanna JG, Wang C, Milette S, Wong C, Usatii M, Giannias B, Mot R, Chandrasekaran A, Moraes C, Huang S, Quail D, Walsh L, Sangwan V, Bertos N, et al. Abstract 2799: Targeting CXCR2-mediated neutrophil recruitment to lung cancer Cancer Research. 79: 2799-2799. DOI: 10.1158/1538-7445.Am2019-2799  0.314
2018 Karimzadeh M, Jandaghi P, Papadakis AI, Trainor S, Rung J, Gonzàlez-Porta M, Scelo G, Vasudev NS, Brazma A, Huang S, Banks RE, Lathrop M, Najafabadi HS, Riazalhosseini Y. Aberration hubs in protein interaction networks highlight actionable targets in cancer. Oncotarget. 9: 25166-25180. PMID 29861861 DOI: 10.18632/Oncotarget.25382  0.378
2018 Perron G, Jandaghi P, Solanki S, Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis AI, Arseneault M, Scelo G, Banks RE, Tost J, Lathrop M, Tanguay S, Brazma A, Huang S, et al. A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes. Cell Reports. 23: 1639-1650. PMID 29742422 DOI: 10.1016/J.Celrep.2018.04.031  0.341
2018 Wang C, Rayes R, Mouhanna J, Giannias B, Chandrasekaran A, Mot R, Moraes C, Huang S, Cools-Lartigue J, Bertos N, Ferri L, Spicer J. Abstract 1099: Molecular drivers of neutrophil recruitment to primary non-small cell lung cancer Cancer Research. 78: 1099-1099. DOI: 10.1158/1538-7445.Am2018-1099  0.359
2017 Zhan Y, Guo J, Yang W, Goncalves C, Rzymski T, Dreas A, Żyłkiewicz E, Mikulski M, Brzózka K, Golas A, Kong Y, Ma M, Huang F, Huor B, Guo Q, ... ... Huang S, et al. MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma. The Journal of Clinical Investigation. PMID 29035277 DOI: 10.1172/Jci91258  0.401
2017 Jandaghi P, Najafabadi HS, Bauer A, Papadakis AI, Fassan M, Hall A, Monast A, Safisamghabadi M, Doeberitz MvK, Neoptolemos JP, Costello E, Greenhalf W, Scarpa A, Sipos B, Auld D, ... ... Huang S, et al. Abstract 1135: DRD2 is critical for pancreatic cancer and promises pharmacological therapy by already established antagonists Cancer Research. 77: 1135-1135. DOI: 10.1158/1538-7445.Am2017-1135  0.356
2016 Jandaghi P, Najafabadi HS, Bauer AS, Papadakis AI, Fassan M, Hall A, Monast A, von Knebel Doeberitz M, Neoptolemos JP, Costello E, Greenhalf W, Scarpa A, Sipos B, Auld D, Lathrop M, ... ... Huang S, et al. Expression of DRD2 is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. Gastroenterology. PMID 27578530 DOI: 10.1053/J.Gastro.2016.08.040  0.319
2015 Adare A, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Akimoto R, Al-Bataineh H, Alexander J, Alfred M, Al-Ta'ani H, Andrews KR, Angerami A, Aoki K, Apadula N, Aphecetche L, ... ... Huang S, et al. Measurements of Elliptic and Triangular Flow in High-Multiplicity 3He+Au Collisions at √(s(NN))=200 GeV. Physical Review Letters. 115: 142301. PMID 26551807 DOI: 10.1103/Physrevlett.115.142301  0.359
2015 Mui MZ, Zhou Y, Blanchette P, Chughtai N, Knight JF, Gruosso T, Papadakis AI, Huang S, Park M, Gingras AC, Branton PE. The human adenovirus type 5 E4orf4 protein targets two phosphatase regulators of the Hippo signaling pathway. Journal of Virology. PMID 26085163 DOI: 10.1128/Jvi.03710-14  0.397
2015 Andrei AZ, Hall A, Smith AL, Bascuñana C, Malina A, Connor A, Altinel-Omeroglu G, Huang S, Pelletier J, Huntsman D, Gallinger S, Omeroglu A, Metrakos P, Zogopoulos G. Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673. Cancer Letters. 364: 8-16. PMID 25864590 DOI: 10.1016/J.Canlet.2015.04.003  0.327
2015 Papadakis AI, Sun C, Knijnenburg TA, Xue Y, Grernrum W, Hölzel M, Nijkamp W, Wessels LF, Beijersbergen RL, Bernards R, Huang S. SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer. Cell Research. 25: 445-58. PMID 25656847 DOI: 10.1038/Cr.2015.16  0.406
2015 Papadakis A, Sun C, Knijnenburg T, Xue Y, Grernrum W, Hölzel M, Nijkamp W, Wessels L, Beijersbergen R, Bernards R, Huang S. Abstract LB-240: SMARCE1 suppresses EGFR expression and controls responses to MET and ALK inhibitors in lung cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Lb-240  0.388
2014 Drosten M, Sum EY, Lechuga CG, Simón-Carrasco L, Jacob HK, García-Medina R, Huang S, Beijersbergen RL, Bernards R, Barbacid M. Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway. Proceedings of the National Academy of Sciences of the United States of America. 111: 15155-60. PMID 25288756 DOI: 10.1073/Pnas.1417549111  0.317
2014 Lai AZ, Cory S, Zhao H, Gigoux M, Monast A, Guiot MC, Huang S, Tofigh A, Thompson C, Naujokas M, Marcus VA, Bertos N, Sehat B, Perera RM, Bell ES, et al. Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer. Science Signaling. 7: ra38. PMID 24757178 DOI: 10.1126/Scisignal.2004839  0.435
2014 Sun C, Hobor S, Bertotti A, Zecchin D, Huang S, Galimi F, Cottino F, Prahallad A, Grernrum W, Tzani A, Schlicker A, Wessels LF, Smit EF, Thunnissen E, Halonen P, et al. Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon cancer through transcriptional induction of ERBB3. Cell Reports. 7: 86-93. PMID 24685132 DOI: 10.1016/J.Celrep.2014.02.045  0.428
2014 Sun C, Wang L, Huang S, Heynen GJ, Prahallad A, Robert C, Haanen J, Blank C, Wesseling J, Willems SM, Zecchin D, Hobor S, Bajpe PK, Lieftink C, Mateus C, et al. Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma. Nature. 508: 118-22. PMID 24670642 DOI: 10.1038/Nature13121  0.347
2013 Walker JA, Gouzi JY, Long JB, Huang S, Maher RC, Xia H, Khalil K, Ray A, Van Vactor D, Bernards R, Bernards A. Genetic and functional studies implicate synaptic overgrowth and ring gland cAMP/PKA signaling defects in the Drosophila melanogaster neurofibromatosis-1 growth deficiency. Plos Genetics. 9: e1003958. PMID 24278035 DOI: 10.1371/Journal.Pgen.1003958  0.395
2013 Bajpe PK, Heynen GJ, Mittempergher L, Grernrum W, de Rink IA, Nijkamp W, Beijersbergen RL, Bernards R, Huang S. The corepressor CTBP2 is a coactivator of retinoic acid receptor/retinoid X receptor in retinoic acid signaling. Molecular and Cellular Biology. 33: 3343-53. PMID 23775127 DOI: 10.1128/Mcb.01213-12  0.326
2012 Huang S, Hölzel M, Knijnenburg T, Schlicker A, Roepman P, McDermott U, Garnett M, Grernrum W, Sun C, Prahallad A, Groenendijk FH, Mittempergher L, Nijkamp W, Neefjes J, Salazar R, et al. MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling Cell. 151: 937-950. PMID 23178117 DOI: 10.1016/J.Cell.2012.10.035  0.401
2012 Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 483: 100-3. PMID 22281684 DOI: 10.1038/Nature10868  0.391
2010 Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron H, Nijkamp W, Xie J, Callens T, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome. Cell. 142: 218-29. PMID 20655465 DOI: 10.1016/J.Cell.2010.06.004  0.316
2010 Hölzel M, Huang S, Koster J, Ora I, Lakeman A, Caron HN, Callens T, Xie J, Nijkamp W, Asgharzadeh S, Seeger RC, Messiaen L, Versteeg R, Bernards R. Abstract A30: NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-A30  0.315
2009 Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R. ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome. Cancer Cell. 15: 328-40. PMID 19345331 DOI: 10.1016/J.Ccr.2009.02.023  0.336
2005 Huang S, O'Shea EK. A systematic high-throughput screen of a yeast deletion collection for mutants defective in PHO5 regulation. Genetics. 169: 1859-71. PMID 15695358 DOI: 10.1534/Genetics.104.038695  0.616
2001 Huang S, Jeffery DA, Anthony MD, O'Shea EK. Functional analysis of the cyclin-dependent kinase inhibitor Pho81 identifies a novel inhibitory domain. Molecular and Cellular Biology. 21: 6695-705. PMID 11533256 DOI: 10.1128/Mcb.21.19.6695-6705.2001  0.659
2001 Piffat KA, Hrdlicková R, Nehyba J, Ikeda T, Liss A, Huang S, Sif S, Gilmore TD, Bose HR. The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB. Molecular Cell Biology Research Communications : McBrc. 4: 266-75. PMID 11529676 DOI: 10.1006/Mcbr.2001.0290  0.304
Show low-probability matches.